Repeat renal allografts treated with sirolimus, cyclosporine, anti-thymocyte globulin induction and continuous steroids achieve similar immunosuppressive efficacy as primary transplants

scientific article published on 19 August 2009

Repeat renal allografts treated with sirolimus, cyclosporine, anti-thymocyte globulin induction and continuous steroids achieve similar immunosuppressive efficacy as primary transplants is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1399-0012.2009.01055.X
P698PubMed publication ID19694771

P2093author name stringBarry D Kahan
Virgilio G Petero
Zsolt Kaposztas
P2860cites workA worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allograftsQ32048820
Living-donor kidney retransplantation: risk factors and outcome.Q35855006
Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro studyQ38525562
Renal retransplantation: a retrospective monocentric studyQ40075915
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignanciesQ42671862
Kidney retransplantation in comparison with first kidney transplantation.Q43450942
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantationQ43453547
Effect of rapamycin and FK506 on mesangial cell proliferationQ43552846
Evaluating the survival benefit of kidney retransplantationQ43961909
Impact of rituximab therapy for treatment of acute humoral rejectionQ45361905
BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomesQ45401963
Influence of number of retransplants on renal graft outcomeQ45826992
The effect of graft nephrectomy on long-term graft function and survival in kidney retransplantationQ46742501
Individualization of immunosuppressive therapy: I. Sirolimus improves outcomes in African-American renal transplant recipientsQ46873844
Second renal transplantations. Ethical issues clarified by outcome; outcome enhanced by a reliable crossmatch.Q53665077
Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progressionQ57362835
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyQ57943257
P433issue2
P921main subjectsirolimusQ32089
cyclosporineQ367700
thymocyteQ7799635
P304page(s)243-251
P577publication date2009-08-19
P1433published inClinical TransplantationQ15754920
P1476titleRepeat renal allografts treated with sirolimus, cyclosporine, anti-thymocyte globulin induction and continuous steroids achieve similar immunosuppressive efficacy as primary transplants
P478volume24

Reverse relations

cites work (P2860)
Q30586178An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival
Q51532710Preemptive use of Mammalian target of rapamycin inhibitors in living donor transplantation.

Search more.